TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
HRTX

Heron Therapeuti

Healthcare · Biotechnology

0.27$ -12.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Heron Therapeuti (HRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow HRTX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-60 -79 -134 -170 -192 -125 -185 -203 -147 -59 -23 -28
0.6 0.7 1.1 1.5 1.5 2.0 2.8 3.0 2.9 2.9 2.5 2.3
8.1 14 26 31 33 51 50 47 43 33 13 10
9.0 14 26 31 33 52 51 48 43
5.9 3.4 11 -5.4 -45 29 -13 -35 -11 17 -28 -32
1.4 1.1 3.1 2.6 9.2 7.2 6.8 3.0 1.8 1.5 1.7 0.3
-1.4 -57 15 7.7 -279 -22 209 33 -3.3 18 19 16
0.0 0.0 0.0 0.0
62 138 7.5 319 383 186 9.1 7.1
50 50 50 -25 -25 0.0 0.0 149 0.0 24 0.0 -13
62 138 57 294 358 186 9.1 156 75 54 0.9 14
0.4 2.5 -62 131 -113 40 33 -15 -75 13 -2.9 2.8
-62 -80 -137 -173 -201 -132 -192 -206 -149 -60 -24 -28

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?